Elizabeth Hagan, Ph.D., focuses her practice on litigation and patent litigation matters to support clients in the life sciences and technology industries.
During law school, Elizabeth was an Intellectual Property Management Intern for the University of Washington Center for Commercialization, and a member of the Entrepreneurial Law Clinic. She performed graduate and post-graduate research in cell and molecular biology. Elizabeth was awarded several academic distinctions as an undergraduate at Wellesley College.
- “Federal Circuit Expands Liability for Divided Patent Infringement”, David Tellekson and Elizabeth B. Hagan, Ph.D., IP Strategist, September 2015
- “XPA Impacts Formation But Not Proteasome-Sensitive Repair of DNA-Protein Cross-links Induced by Chromate”, Mutagenesis, Vol. 25 No. 4, pp.381-388, 2010. (co-author)
- “Mechanism of DNA-Protein Crosslinking by Chromium,” Chemical Research in Toxology, Vol. 23 No. 2 ,pp. 341-347, 2010. (co-author)
- “WRN Helicase Promotes Repair of DNA Double-Strand Breaks Caused by Aberrant Mismatch Repair of Chromium-DNA Adducts,” Cell Cycle, Vo. 8, pp. 2769-2778, 2009. (co-author)
- “Do Not Cross Your DNA”, Chemical Research in Toxology, Vol. 21, pp. 274-275, 2008. (co-author)